Author Archives:

RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of Next-Generation Cell Therapy for Patients with Duchenne Muscular Dystrophy

RESTEM Developing First-in-Class, Umbilical Cord Lining Stem Cell Therapies. JAR of Hope Providing Critical Philanthropic Financial Support for Clinical Trial. CORONA, CALIF. AND ASBURY PARK, N.J. (PRWEB) SEPTEMBER 06, 2022 RESTEM, a pioneering, next-generation, clinical-stage cell therapy company focused on harnessing the unique power of cell therapy and JAR of Hope, a 501(3)(C) non-profit foundation dedicated […]

Benefits of Stem Cell Research

It’s no secret that stem cells are revolutionizing the healthcare field. Stem cell research is so exciting because it encourages the idea that there may be relief to those suffering from autoimmune diseases. Stem cell research gives us the hope that we can live fully without fear of age-related degenerative diseases. Maybe we even have […]

UF Center for Regenerative Medicine recruiting for trial on potential therapy for autoimmune disorders

Published: Aug 2, 2022 By: Bill Levesque The University of Florida Center for Regenerative Medicine today announced the launch of a clinical trial to test safe dosages of umbilical cord-derived stem cells in the treatment of two debilitating autoimmune disorders. The Phase I trial, in collaboration with the biotechnology company RESTEM, will include nine patients who will receive intravenous […]